Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
Use of blood based biomarkers in the evaluation of Crohn's disease and ulcerative colitis.

World journal of gastrointestinal endoscopy

Barnes EL, Liew CC, Chao S, Burakoff R.
PMID: 26634038
World J Gastrointest Endosc. 2015 Nov 25;7(17):1233-7. doi: 10.4253/wjge.v7.i17.1233.

Despite significant improvements in our understanding of Crohn's disease (CD) and ulcerative colitis (UC) in recent years, questions remain regarding the best approaches to assessment and management of these chronic diseases during periods of both relapse and remission. Various...

Cite
Barnes EL, Liew CC, Chao S, et al. Use of blood based biomarkers in the evaluation of Crohn's disease and ulcerative colitis. World J Gastrointest Endosc. 2015;7(17):1233-7doi: 10.4253/wjge.v7.i17.1233.
Barnes, E. L., Liew, C. C., Chao, S., & Burakoff, R. (2015). Use of blood based biomarkers in the evaluation of Crohn's disease and ulcerative colitis. World journal of gastrointestinal endoscopy, 7(17), 1233-7. https://doi.org/10.4253/wjge.v7.i17.1233
Barnes, Edward L, et al. "Use of blood based biomarkers in the evaluation of Crohn's disease and ulcerative colitis." World journal of gastrointestinal endoscopy vol. 7,17 (2015): 1233-7. doi: https://doi.org/10.4253/wjge.v7.i17.1233
Barnes EL, Liew CC, Chao S, Burakoff R. Use of blood based biomarkers in the evaluation of Crohn's disease and ulcerative colitis. World J Gastrointest Endosc. 2015 Nov 25;7(17):1233-7. doi: 10.4253/wjge.v7.i17.1233. PMID: 26634038; PMCID: PMC4658602.
Copy Download .nbib Format: NLM
Alkylating HIV-1 Nef - a potential way of HIV intervention.

AIDS research and therapy

Jin YJ, Zhang X, Cai CY, Burakoff SJ.
PMID: 20659345
AIDS Res Ther. 2010 Jul 26;7:26. doi: 10.1186/1742-6405-7-26.

BACKGROUND: Nef is a 27 KDa HIV-1 accessory protein. It downregulates CD4 from infected cell surface, a mechanism critical for efficient viral replication and pathogenicity. Agents that antagonize the Nef-mediated CD4 downregulation may offer a new class of drug...

Cite
Jin YJ, Zhang X, Cai CY, et al. Alkylating HIV-1 Nef - a potential way of HIV intervention. AIDS Res Ther. 2010;7:26doi: 10.1186/1742-6405-7-26.
Jin, Y. J., Zhang, X., Cai, C. Y., & Burakoff, S. J. (2010). Alkylating HIV-1 Nef - a potential way of HIV intervention. AIDS research and therapy, 726. https://doi.org/10.1186/1742-6405-7-26
Jin, Yong-Jiu, et al. "Alkylating HIV-1 Nef - a potential way of HIV intervention." AIDS research and therapy vol. 7 (2010): 26. doi: https://doi.org/10.1186/1742-6405-7-26
Jin YJ, Zhang X, Cai CY, Burakoff SJ. Alkylating HIV-1 Nef - a potential way of HIV intervention. AIDS Res Ther. 2010 Jul 26;7:26. doi: 10.1186/1742-6405-7-26. PMID: 20659345; PMCID: PMC2917394.
Copy Download .nbib Format: NLM
Sensitivity analysis of geometrical parameters to study haemodynamics and thrombus formation in the left atrial appendage.

International journal for numerical methods in biomedical engineering

García-Isla G, Olivares AL, Silva E, Nuñez-Garcia M, Butakoff C, Sanchez-Quintana D, G Morales H, Freixa X, Noailly J, De Potter T, Camara O.
PMID: 29737037
Int J Numer Method Biomed Eng. 2018 May 08;e3100. doi: 10.1002/cnm.3100. Epub 2018 May 08.

The left atrial appendage (LAA) is a complex and heterogeneous protruding structure of the left atrium (LA). In atrial fibrillation patients, it is the location where 90% of the thrombi are formed. However, the role of the LAA in...

Cite
García-Isla G, Olivares AL, Silva E, et al. Sensitivity analysis of geometrical parameters to study haemodynamics and thrombus formation in the left atrial appendage. Int J Numer Method Biomed Eng. 2018;e3100doi: 10.1002/cnm.3100.
García-Isla, G., Olivares, A. L., Silva, E., Nuñez-Garcia, M., Butakoff, C., Sanchez-Quintana, D., G Morales, H., Freixa, X., Noailly, J., De Potter, T., & Camara, O. (2018). Sensitivity analysis of geometrical parameters to study haemodynamics and thrombus formation in the left atrial appendage. International journal for numerical methods in biomedical engineering, e3100. https://doi.org/10.1002/cnm.3100
García-Isla, Guadalupe, et al. "Sensitivity analysis of geometrical parameters to study haemodynamics and thrombus formation in the left atrial appendage." International journal for numerical methods in biomedical engineering vol. (2018): e3100. doi: https://doi.org/10.1002/cnm.3100
García-Isla G, Olivares AL, Silva E, Nuñez-Garcia M, Butakoff C, Sanchez-Quintana D, G Morales H, Freixa X, Noailly J, De Potter T, Camara O. Sensitivity analysis of geometrical parameters to study haemodynamics and thrombus formation in the left atrial appendage. Int J Numer Method Biomed Eng. 2018 May 08;e3100. doi: 10.1002/cnm.3100. Epub 2018 May 08. PMID: 29737037.
Copy Download .nbib Format: NLM
Abnormal Bolus Reflux Is Associated With Poor Pulmonary Outcome in Patients With Idiopathic Pulmonary Fibrosis.

Journal of neurogastroenterology and motility

Borges LF, Jagadeesan V, Goldberg H, Gavini S, Lo WK, Burakoff R, Feldman N, Chan WW.
PMID: 29969857
J Neurogastroenterol Motil. 2018 Jul 30;24(3):395-402. doi: 10.5056/jnm18023.

BACKGROUND/AIMS: Gastroesophageal reflux (GER) is postulated to play a role in idiopathic pulmonary fibrosis (IPF). However, the value of objective GER measures in predicting IPF disease progression is unclear. We aim to evaluate the association between objective GER measures...

Cite
Borges LF, Jagadeesan V, Goldberg H, et al. Abnormal Bolus Reflux Is Associated With Poor Pulmonary Outcome in Patients With Idiopathic Pulmonary Fibrosis. J Neurogastroenterol Motil. 2018;24(3):395-402doi: 10.5056/jnm18023.
Borges, L. F., Jagadeesan, V., Goldberg, H., Gavini, S., Lo, W. K., Burakoff, R., Feldman, N., & Chan, W. W. (2018). Abnormal Bolus Reflux Is Associated With Poor Pulmonary Outcome in Patients With Idiopathic Pulmonary Fibrosis. Journal of neurogastroenterology and motility, 24(3), 395-402. https://doi.org/10.5056/jnm18023
Borges, Lawrence F, et al. "Abnormal Bolus Reflux Is Associated With Poor Pulmonary Outcome in Patients With Idiopathic Pulmonary Fibrosis." Journal of neurogastroenterology and motility vol. 24,3 (2018): 395-402. doi: https://doi.org/10.5056/jnm18023
Borges LF, Jagadeesan V, Goldberg H, Gavini S, Lo WK, Burakoff R, Feldman N, Chan WW. Abnormal Bolus Reflux Is Associated With Poor Pulmonary Outcome in Patients With Idiopathic Pulmonary Fibrosis. J Neurogastroenterol Motil. 2018 Jul 30;24(3):395-402. doi: 10.5056/jnm18023. PMID: 29969857; PMCID: PMC6034669.
Copy Download .nbib Format: NLM
A Successful Dental Care Referral Program for Low-Income Pregnant Women in New York.

International journal of environmental research and public health

Russell SL, Kerpen SJ, Rabin JM, Burakoff RP, Yang C, Huang SS.
PMID: 34886450
Int J Environ Res Public Health. 2021 Dec 02;18(23). doi: 10.3390/ijerph182312724.

Despite evidence-based guidelines that advocate for dental care during pregnancy, dental utilization among pregnant women remains low, especially among low-income and racial-ethnic minority women. We investigated self-reported dental care referral and self-reported dental care attendance among a group of...

Cite
Russell SL, Kerpen SJ, Rabin JM, et al. A Successful Dental Care Referral Program for Low-Income Pregnant Women in New York. Int J Environ Res Public Health. 2021;18(23)doi: 10.3390/ijerph182312724.
Russell, S. L., Kerpen, S. J., Rabin, J. M., Burakoff, R. P., Yang, C., & Huang, S. S. (2021). A Successful Dental Care Referral Program for Low-Income Pregnant Women in New York. International journal of environmental research and public health, 18(23), . https://doi.org/10.3390/ijerph182312724
Russell, Stefanie L, et al. "A Successful Dental Care Referral Program for Low-Income Pregnant Women in New York." International journal of environmental research and public health vol. 18,23 (2021). doi: https://doi.org/10.3390/ijerph182312724
Russell SL, Kerpen SJ, Rabin JM, Burakoff RP, Yang C, Huang SS. A Successful Dental Care Referral Program for Low-Income Pregnant Women in New York. Int J Environ Res Public Health. 2021 Dec 02;18(23). doi: 10.3390/ijerph182312724. PMID: 34886450.
Copy Download .nbib Format: NLM
Exercise Capacity in Young Adults Born Small for Gestational Age.

JAMA cardiology

Crispi F, Rodríguez-López M, Bernardino G, Sepúlveda-Martínez Á, Prat-González S, Pajuelo C, Perea RJ, Caralt MT, Casu G, Vellvé K, Crovetto F, Burgos F, De Craene M, Butakoff C, González Ballester MÁ, Blanco I, Sitges M, Bijnens B, Gratacós E.
PMID: 34287644
JAMA Cardiol. 2021 Nov 01;6(11):1308-1316. doi: 10.1001/jamacardio.2021.2537.

IMPORTANCE: Being born small for gestational age (SGA), approximately 10% of all births, is associated with increased risk of cardiovascular mortality in adulthood, but mechanistic pathways are unclear. Cardiac remodeling and dysfunction occur in fetuses SGA and children born...

Cite
Crispi F, Rodríguez-López M, Bernardino G, et al. Exercise Capacity in Young Adults Born Small for Gestational Age. JAMA Cardiol. 2021;6(11):1308-1316doi: 10.1001/jamacardio.2021.2537.
Crispi, F., Rodríguez-López, M., Bernardino, G., Sepúlveda-Martínez, �. �., Prat-González, S., Pajuelo, C., Perea, R. J., Caralt, M. T., Casu, G., Vellvé, K., Crovetto, F., Burgos, F., De Craene, M., Butakoff, C., González Ballester, M. �. �., Blanco, I., Sitges, M., Bijnens, B., & Gratacós, E. (2021). Exercise Capacity in Young Adults Born Small for Gestational Age. JAMA cardiology, 6(11), 1308-1316. https://doi.org/10.1001/jamacardio.2021.2537
Crispi, Fàtima, et al. "Exercise Capacity in Young Adults Born Small for Gestational Age." JAMA cardiology vol. 6,11 (2021): 1308-1316. doi: https://doi.org/10.1001/jamacardio.2021.2537
Crispi F, Rodríguez-López M, Bernardino G, Sepúlveda-Martínez Á, Prat-González S, Pajuelo C, Perea RJ, Caralt MT, Casu G, Vellvé K, Crovetto F, Burgos F, De Craene M, Butakoff C, González Ballester MÁ, Blanco I, Sitges M, Bijnens B, Gratacós E. Exercise Capacity in Young Adults Born Small for Gestational Age. JAMA Cardiol. 2021 Nov 01;6(11):1308-1316. doi: 10.1001/jamacardio.2021.2537. PMID: 34287644; PMCID: PMC8576583.
Copy Download .nbib Format: NLM
Notes from the Field: Hantavirus Pulmonary Syndrome - Denver, Colorado, 2018.

MMWR. Morbidity and mortality weekly report

Tobolowsky F, Burakoff A, House J, Marzec N, Neumeier A, Sparks P, McLees M.
PMID: 31487276
MMWR Morb Mortal Wkly Rep. 2019 Sep 06;68(35):771-772. doi: 10.15585/mmwr.mm6835a5.

No abstract available.

Cite
Tobolowsky F, Burakoff A, House J, et al. Notes from the Field: Hantavirus Pulmonary Syndrome - Denver, Colorado, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(35):771-772doi: 10.15585/mmwr.mm6835a5.
Tobolowsky, F., Burakoff, A., House, J., Marzec, N., Neumeier, A., Sparks, P., & McLees, M. (2019). Notes from the Field: Hantavirus Pulmonary Syndrome - Denver, Colorado, 2018. MMWR. Morbidity and mortality weekly report, 68(35), 771-772. https://doi.org/10.15585/mmwr.mm6835a5
Tobolowsky, Farrell, et al. "Notes from the Field: Hantavirus Pulmonary Syndrome - Denver, Colorado, 2018." MMWR. Morbidity and mortality weekly report vol. 68,35 (2019): 771-772. doi: https://doi.org/10.15585/mmwr.mm6835a5
Tobolowsky F, Burakoff A, House J, Marzec N, Neumeier A, Sparks P, McLees M. Notes from the Field: Hantavirus Pulmonary Syndrome - Denver, Colorado, 2018. MMWR Morb Mortal Wkly Rep. 2019 Sep 06;68(35):771-772. doi: 10.15585/mmwr.mm6835a5. PMID: 31487276.
Copy Download .nbib Format: NLM
Extraintestinal manifestations of inflammatory bowel disease.

Gastroenterology & hepatology

Levine JS, Burakoff R.
PMID: 21857821
Gastroenterol Hepatol (N Y). 2011 Apr;7(4):235-41.

Extraintestinal manifestations of inflammatory bowel disease are prevalent in both ulcerative colitis and Crohn's disease. The most common manifestations involve the musculoskeletal and dermatologic systems. Other manifestations involve the hepatopan-creatobiliary system (eg, primary sclerosing cholangitis) as well as the...

Cite
Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2011;7(4):235-41
Levine, J. S., & Burakoff, R. (2011). Extraintestinal manifestations of inflammatory bowel disease. Gastroenterology & hepatology, 7(4), 235-41.
Levine, Jonathan S, and Burakoff, Robert. "Extraintestinal manifestations of inflammatory bowel disease." Gastroenterology & hepatology vol. 7,4 (2011): 235-41.
Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2011 Apr;7(4):235-41. PMID: 21857821; PMCID: PMC3127025.
Copy Download .nbib Format: NLM
Characteristics of phase-aberrated nondiffraction-limited laser beams.

Applied optics

Hogge CB, Butts RR, Burlakoff M.
PMID: 20126134
Appl Opt. 1974 May 01;13(5):1065-70. doi: 10.1364/AO.13.001065.

To simulate nondiffraction-limited laser beams numerically, one needs to understand their nature better. For a phase aberration the correlation length of which is much less than the width of the beam, one can show that the far-field irradiance distribution...

Cite
Hogge CB, Butts RR, Burlakoff M. Characteristics of phase-aberrated nondiffraction-limited laser beams. Appl Opt. 1974;13(5):1065-70doi: 10.1364/AO.13.001065.
Hogge, C. B., Butts, R. R., & Burlakoff, M. (1974). Characteristics of phase-aberrated nondiffraction-limited laser beams. Applied optics, 13(5), 1065-70. https://doi.org/10.1364/AO.13.001065
Hogge, C B, et al. "Characteristics of phase-aberrated nondiffraction-limited laser beams." Applied optics vol. 13,5 (1974): 1065-70. doi: https://doi.org/10.1364/AO.13.001065
Hogge CB, Butts RR, Burlakoff M. Characteristics of phase-aberrated nondiffraction-limited laser beams. Appl Opt. 1974 May 01;13(5):1065-70. doi: 10.1364/AO.13.001065. PMID: 20126134.
Copy Download .nbib Format: NLM
Review.

Gastroenterology & hepatology

Pabby V, Burakoff R.
PMID: 24719608
Gastroenterol Hepatol (N Y). 2013 Aug;9(8):543-4.

No abstract available.

Cite
Pabby V, Burakoff R. Review. Gastroenterol Hepatol (N Y). 2013;9(8):543-4
Pabby, V., & Burakoff, R. (2013). Review. Gastroenterology & hepatology, 9(8), 543-4.
Pabby, Vikas, and Burakoff, Robert. "Review." Gastroenterology & hepatology vol. 9,8 (2013): 543-4.
Pabby V, Burakoff R. Review. Gastroenterol Hepatol (N Y). 2013 Aug;9(8):543-4. PMID: 24719608; PMCID: PMC3981003.
Copy Download .nbib Format: NLM
Measurement of Calcineurin Phosphatase Activity in Cell Extracts.

Methods (San Diego, Calif.)

Fruman DA, Pai SY, Klee CB, Burakoff SJ, Bierer BE.
PMID: 8812656
Methods. 1996 Apr;9(2):146-54. doi: 10.1006/meth.1996.0020.

The calmodulin-dependent phosphatase calcineurin is an important molecular target of the immunosuppressive drugs cyclosporin A (CsA) and FK506. Complexes of CsA and FK506 with their immunophilin ligands interact with calcineurin in vitro, resulting in the inhibition of its serine/threonine...

Cite
Fruman DA, Pai SY, Klee CB, et al. Measurement of Calcineurin Phosphatase Activity in Cell Extracts. Methods. 1996;9(2):146-54doi: 10.1006/meth.1996.0020.
Fruman, D. A., Pai, S. Y., Klee, C. B., Burakoff, S. J., & Bierer, B. E. (1996). Measurement of Calcineurin Phosphatase Activity in Cell Extracts. Methods (San Diego, Calif.), 9(2), 146-54. https://doi.org/10.1006/meth.1996.0020
Fruman, et al. "Measurement of Calcineurin Phosphatase Activity in Cell Extracts." Methods (San Diego, Calif.) vol. 9,2 (1996): 146-54. doi: https://doi.org/10.1006/meth.1996.0020
Fruman DA, Pai SY, Klee CB, Burakoff SJ, Bierer BE. Measurement of Calcineurin Phosphatase Activity in Cell Extracts. Methods. 1996 Apr;9(2):146-54. doi: 10.1006/meth.1996.0020. PMID: 8812656.
Copy Download .nbib Format: NLM
The role of mesalamine in the treatment of ulcerative colitis.

Therapeutics and clinical risk management

Karagozian R, Burakoff R.
PMID: 18473013
Ther Clin Risk Manag. 2007 Oct;3(5):893-903.

Ulcerative colitis (UC) is a chronic inflammatory condition of unclear etiology affecting the large bowel, most commonly the rectum and extending proximally in a continuous fashion. The overall principle in the pathophysiolgy of ulcerative colitis is the dysregulation of...

Cite
Karagozian R, Burakoff R. The role of mesalamine in the treatment of ulcerative colitis. Ther Clin Risk Manag. 2007;3(5):893-903
Karagozian, R., & Burakoff, R. (2007). The role of mesalamine in the treatment of ulcerative colitis. Therapeutics and clinical risk management, 3(5), 893-903.
Karagozian, Raffi, and Burakoff, Robert. "The role of mesalamine in the treatment of ulcerative colitis." Therapeutics and clinical risk management vol. 3,5 (2007): 893-903.
Karagozian R, Burakoff R. The role of mesalamine in the treatment of ulcerative colitis. Ther Clin Risk Manag. 2007 Oct;3(5):893-903. PMID: 18473013; PMCID: PMC2376091.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries